2022 Speakers

Born to a poor immigrant family in New York City, Richard Carmona experienced homelessness, hunger, and health disparities during his youth. The experiences greatly sensitized him to the relationships among culture, health, education and economic status and ultimately shaped his future.

After dropping out of high school, Dr. Carmona enlisted in the U.S. Army in 1967 where he received a GED. By the time he left active duty, he was a Special Forces, combat-decorated Vietnam veteran. He then pursued a college degree and entered medical school at the University of California – San Francisco where he won the prestigious Gold Cane award as the top graduate.

Dr. Carmona became a surgeon with a sub-specialty in trauma, burns and critical care and was recruited to Tucson to establish the first trauma system in southern Arizona which he did successfully. Later, while working full time as a hospital and health system CEO, he earned a master’s degree in public health policy and administration at the University of Arizona.

Dr. Carmona has served for over 34 years with the Pima County Sheriff’s Department in Tucson, including as deputy sheriff, detective, SWAT team leader and department surgeon. He is one of the most highly decorated police officers in Arizona, and his numerous awards include the National Top Cop Award, the National SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona is a nationally recognized SWAT expert and has published extensively on SWAT training and tactics, forensics, and tactical emergency medical support. Dr. Carmona has also served as a medical director of police and fire departments and is a fully qualified peace officer with expertise in special operations and emergency preparedness, including weapons of mass destruction.

In 2006 Vice Admiral Carmona successfully completed the statutory four-year term as Surgeon General and was named vice chairman of Canyon Ranch, CEO of the health division and president of the Canyon Ranch Institute. Dr. Carmona continues his Canyon Ranch leadership role as the Chief of Health Innovations. He also serves on several public corporate boards and works with private equity and venture capital firms to identify emerging science and technology to translate to market for economic and public benefit.

Michelle A. Williams, SM ’88, ScD ’91, is Dean of the Faculty, Harvard T.H. Chan School of Public Health, and Angelopoulos Professor in Public Health and International Development, a joint faculty appointment at the Harvard Chan School and Harvard Kennedy School. She is an internationally renowned epidemiologist and public health scientist, an award-winning educator, and a widely recognized academic leader. Prior to becoming Dean, she was Professor and Chair of the Department of Epidemiology at the Harvard Chan School and Program Leader of the Population Health and Health Disparities Research Programs at Harvard’s Clinical and Translational Sciences Center. Dean Williams previously had a distinguished career at the University of Washington School of Public Health. Her scientific work places special emphasis in the areas of reproductive, perinatal, pediatric, and molecular epidemiology. Dean Williams has published more than 500 scientific articles and was elected to the National Academy of Medicine in 2016. In 2020, she was awarded the Ellis Island Medal of Honor and recognized by PR Week as one of the top 50 health influencers of the year. The Dean has an undergraduate degree in biology and genetics from Princeton University, a master’s in civil engineering from Tufts University, and master’s and doctoral degrees in epidemiology from the Harvard Chan School.

Gloria Caulfield leads health and wellness strategy and planning for the Lake Nona Institute. Gloria is passionate about identifying partners who are skillful at collaboration and have the desire to innovate solutions that have the potential to move the needle on community health and wellness.

William Jefferson Clinton, the first Democratic president in six decades to be elected twice, led the United States to the longest economic expansion in American history, including the creation of more than 22 million jobs.

After leaving the White House, President Clinton established the Clinton Foundation in order to continue working on the causes he cared about. Since its founding, the Foundation has endeavored to help build more resilient communities by developing and implementing programs that improve people’s health, strengthen local economies, and protect the environment.

The Foundation is guided by the belief that every problem has a solution and together with a diverse set of partners, works to improve lives around the globe and across the United States through a wide range of initiatives, including the now independent Clinton Health Access Initiative (CHAI), which has helped over 11 million people in more than 70 countries access critical HIV/AIDS medications at CHAI-negotiated prices. The Clinton Climate Initiative, the Clinton Development Initiative, and the Clinton Giustra Enterprise Partnership are applying a business-oriented approach to promote sustainable economic growth and fight climate change in Africa, Latin America, Asia, and the Caribbean. In the United States, the Foundation is focused on helping children and adults live full and active lives by working to combat the rise in childhood obesity through the Alliance for a Healthier Generation, a partnership forged with the American Heart Association; reduce health disparities and address emerging health threats like the opioid epidemic by partnering with local communities through the Clinton Health Matters Initiative; and increase awareness about the importance of early childhood development through the Foundation’s Too Small to Fail initiative.

The Clinton Presidential Center in Little Rock remains the heart and soul of the Clinton Foundation, and since it opened its doors in 2004, the Clinton Center has hosted hundreds of thousands of visitors each year, catalyzing $3.3 billion in economic impact throughout the community. Today, the Clinton Center also cooperatively manages the Presidential Leadership Scholars Program—a joint effort between the George W. Bush Presidential Center, the George Bush Presidential Library Foundation, and the Lyndon Baines Johnson Foundation that seeks to equip emerging leaders with the tools they need to drive positive change in their communities.
Above all, President Clinton has always believed that we can do more together than any of us can do on our own. In 2005, he founded the Clinton Global Initiative to foster partnerships among governments, businesses, nongovernmental organizations and private citizens to turn good ideas into measurable results. To date, over 3,600 CGI commitments have already improved the lives of more than 435 million people in more than 180 countries. CGI’s work continues through these ongoing commitments and through the Clinton Global Initiative University which this year, celebrates 10 years of bringing together college and university students from every corner of the globe to turn good ideas into action.

In addition to his continuing roles with the Foundation and CHAI, President Clinton has joined with other former Presidents to support relief efforts for communities recovering from natural disasters—partnering with President George H.W. Bush three times to organize aid and support for those affected by the 2004 tsunami in South Asia, Hurricane Katrina in 2005, and Hurricane Ike in 2008, and with President George W. Bush in the aftermath of the 2010 earthquake in Haiti to raise money and assistance for communities devastated by the storm. To this day, the Clinton Foundation continues to support economic growth, job creation and sustainability in communities across Haiti.

President Clinton was born on August 19, 1946, in Hope, Arkansas. He and his wife Secretary Hillary Rodham Clinton have one daughter, Chelsea; two grandchildren, and live in Chappaqua, New York.

Victor is a non-Executive Director of the Co-Operative Group, Collaborate CIC and Nuffield Health. Chair and Co-Founder of Visionable and Founder of Leadership in Mind. He is Chair of Social Enterprise UK and the NHS Confederation. Victor has recently stepped down as the CEO of Turning Point, a social enterprise providing health and social care interventions to approximately 100,000 people per year. Victor also served as a Non-Executive Director on the board of NHS England. He has chaired a number of commission reports into: policing; employment; mental health; housing and fairness for The London Fairness Commission; the Metropolitan Police; and for central and local government. He was awarded a CBE for services to the unemployed and homeless people, and became a crossbench peer in 2001.

Victor is a visiting Professor and Chancellor at the University of Lincoln; an honorary member of the Institute of Psychiatry; President of The International Association of Philosophy and Psychiatry and a Governor at The London School of Economics.

Victor has an MA in Advanced Organisational Consulting from Tavistock Institute and City University.

Dr. Joseph G. Allen is an associate professor at the Harvard T.H. Chan School of Public Health, director of Harvard’s Healthy Buildings Program, and the coauthor of Healthy Buildings: How Indoor Spaces Drive Performance and Productivity, which was selected as ‘Best Book of the Year’ by the New York Times and Fortune. During the Covid-19 pandemic, Dr. Allen has served as commissioner of The Lancet Covid-19 Commission and Chair of its Task Force of Safe Work, Safe Schools, and Safe Travel.

An internationally renowned expert and sought-after adviser, Dr. Allen’s work fuses the fields of health science, building science, and business science to improve the health of indoor spaces and drive business performance. He has authored over eighty peer-reviewed scientific papers—including in such journals as JAMA, Science, and The Lancet—and regularly contributes to the New York Times, Washington Post, and Wall Street Journal.

Dr. Kelvin A. Baggett is a nationally recognized healthcare leader with experience as a physician, clinical leader, operator, advisor and investor. He brings a richly informed point of view on health and healthcare and how to make improvements at scale. That perspective was shaped through his positions in senior management and executive leadership positions in large complex organizations.

Currently, Kelvin serves as Chief Impact Officer and Executive Vice President at McKesson Corporation, a Fortune 7 Company. Prior to joining McKesson, Kelvin served as Managing Director, Posterity Capital Group, a healthcare-dedicated investment firm targeting early to mid-stage companies that enable improvements in health and wellness. He also served as a Senior Advisor to Pharos Capital Group, a middle market healthcare private equity firm committed to investing in companies that reduce the total costs of care and improve outcomes.

Kelvin’s career also includes serving as the Chief Operating Officer (COO) for Health Care Navigator (HCN), a privately held asset management company focused on the post-acute care and long-term care entities in multiple states; and SVP of Clinical Operations and Chief Clinical Officer for Tenet Healthcare Corporation, were he was also previously the Chief Medical Officer. Before joining Tenet, Kelvin served as Chief Operating Officer, Clinical Services Group and VP of Clinical Strategies at Hospital Corporation of America (HCA), the largest investor owned healthcare system.

During the COVID-19 pandemic, Kelvin served our City, in a voluntary capacity, as the Dallas COVID-19 Health and Healthcare Access Czar.

Kelvin completed his training in Internal Medicine at the Yale University School of Medicine. He completed advanced training as a Robert Wood Johnson Clinical Scholar in the Department of Medicine at the Johns Hopkins University School of Medicine and as a General Internal Medicine Fellow at the Duke University School of Medicine. Kelvin earned his B.S. in Biology from the University of North Carolina at Chapel Hill, a Doctor of Medicine Degree from the East Carolina University School of Medicine, a Master of Public Health Degree from the Johns Hopkins Bloomberg School of Public Health and a Master of Business Administration from the Fuqua School of Business at Duke University.

He resides in Dallas, Texas with his wife and two young children.

Dr. Bobby G. Baker is the Chief Community Engagement Officer at Christ Community Health Services. His previous work at Methodist LeBonheur Healthcare with the Congregational Health Network (CHN) has been recognized as a National Best Practice and cited by The Agency for Health Research and Quality (AHRQ). The CHN, an asset based, faith centered community health intervention, focused on patient navigation, grew to more than 500 partner congregations and reported a cost savings of $1,200,000 in healthcare expense system-wide. Dr. Bobby G. Baker also currently serves as Senior Pastor of Divine Faith Church in Memphis, Tennessee.

Dr. Barzilai is a chaired Professor of Medicine and Genetics and Director of the biggest Center in the world to study the Biology of Aging and the principal investigator of the Einstein Nathan Shock Center and the Glenn center. He was the recipient of an NIH Merit Award aiming to extend the healthy life span in rodents by biological interventions. He also studies families of centenarians that have provided genetic/biological insights on the protection against aging. Several drugs are developed based, in part, on these paradigm-changing studies. He is the author of over 270 peer-reviewed papers and a recipient of numerous prestigious awards, including the recipient of the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions. He is a founder of CohBar Inc. (now public company) and Medical Advisor for Life Biosciences. He is on the board of AFAR, its scientific director and a founding member of the Academy for Lifespan and Health span. He co-founded CohBar and Lifebioscinces. He has been featured in major papers, TV program and documentaries (2 TEDx and TEDMED) and has been consulting or presented the promise for targeting aging at The Singapore Prime Minister Office, Prime Minister office in Israel, several International Banks, The Vatican, Pepsico, Milken Institute, Davos Economical Forum, and featured in The Wall Street Journal, New York Times, The Economist and Wired Magazine. His book Age Later was published in the June of 2020

Debika Bhattacharya is Senior Vice President of 5G & Enterprise Solutions for Verizon Business, charged with delivering 5G solutions and strategic business outcomes to Verizon’s Global Enterprise and Government customers. She leads a team of 1,100+ sales and technology professionals across 20 countries.

Debika’s current focus is on delivering business value to clients through Verizon’s best in class solutions such as 5G, edge computing, software-defined services, and digital collaboration, partnering with customers to navigate the challenges of today while building the foundation for future success.

As a seasoned global executive, Debika has extensive experience leading complex technology projects for Fortune 1000 clients, guiding successful IT transformations in healthcare, retail, manufacturing, and financial services. She has held a variety of executive roles within Verizon, including an assignment in Europe. She was instrumental in the global expansion of Verizon’s communications network, as well as the deployment of breakthrough optical wave technologies.

Debika holds advanced degrees in electrical engineering and physics from the Massachusetts Institute of Technology and the State University of New York. She serves as an industry liaison to the MIT community and supports outreach programs aimed at increasing the participation of women and minorities in science and engineering. She is also active in IEEE-Women in Engineering and the Society of Women Engineers.

Juju Chang is an Emmy® Award-winning co-anchor of ABC News’ “Nightline.” She also reports regularly for “Good Morning America” and “20/20.” Chang reported on the recent rise of hate crimes toward the Asian American and Pacific Islander (AAPI) community as anchor of the ABC News Live special “Stop The Hate: The Rise In Violence Against Asian Americans” and the “20/20” special “Murder In Atlanta” following the Atlanta mass shooting.

Chang has been recognized for her in-depth personal narratives set against the backdrop of pressing national and international news. Her recent reports include a critical examination of the controversial Migrant Protection Protocols (MPP) known as the “Remain in Mexico” immigration policy. The story was told through the eyes of one pregnant woman and her family among the 60,000 asylum seekers camped for months along the Rio Grande. Chang’s award-winning report on violence against transgender women of color across the country caps a series of her stories on LGBTQ+ issues. Chang won a GLAAD award for her story on the 25th anniversary of Matthew Shepard’s murder and the legacy his parents have built in his honor. Chang’s exclusive television interview with transgender solider Chelsea Manning, after seven years in prison, explored issues of national security leaks, medical treatment for incarcerated transgender people and LGBTQ+ military service.

Chang has covered the major breaking news for decades for ABC News, including the extensive COVID-19 science and the fallout on hospital ICU’s, health care and essential workers. Chang covered Superstorm Sandy, the Orlando nightclub massacre and the Boston Marathon bombing.

She has traveled around the world to report on global issues and gender-based violence, including a trip through Central Africa on the front lines against Boko Haram and #bringbackourgirls. She traveled to Honduras for “Femicide: the Untold War,” an eye-opening look at rampant violence against women.

Chang has profiled newsmakers like Facebook COO Sheryl Sandberg, former Vice President Joe Biden and Oprah Winfrey as well as entertainers like Chris Pratt, Channing Tatum, Tom Hanks and Nicki Minaj. Her extensive feature reporting covers parenting dilemmas, digital addictions and social media moguls like Dude Perfect and Kendall Jenner.

A former news anchor for “Good Morning America,” Chang joined ABC News just after college as an entry-level desk assistant in 1987 and rose to become a producer for “World News Tonight.” After reporting for KGO-TV in San Francisco and the ABC News affiliate service NewsOne in Washington, D.C., she co-anchored the overnight show “World News Now.” Chang’s work has been recognized with numerous awards, including multiple Emmy’s, Gracie’s, a DuPont, a Murrow and Peabody awards. In 2017, she was honored with the Lifetime Achievement Award at the Front Page Awards.

Born in Seoul, South Korea, and raised in Northern California, Chang graduated with honors from Stanford University with a Bachelor of Arts in political science and communication. She is married to WNET president and CEO Neal Shapiro and, together, they have three sons. Chang is a member of the Council on Foreign Relations and a founding board member of the Korean American Community Foundation.

Ciara is a Grammy Award-winning singer/songwriter, entrepreneur, and philanthropist. Over her fifteen-year career, she has sold over 23 million records and 22 million singles worldwide, including chart-topping hits “Goodies,” “Ride,” “Oh,” “1, 2 Step,” “I Bet,” and “Level Up.” Ciara is not only known for her vocal talent and dance moves (her videos have been viewed over 2 billion times), but she has starred in both film and television roles. Ciara is the founder and CEO of Beauty Marks Entertainment (BME), a company at the vanguard of the fast-changing music industry. With a business model built on fully supporting the artist, the female-led enterprise places Ciara at the forefront of forward-thinking entertainers taking an entrepreneurial approach to their careers. To that end, the company positions music at the intersection of Ciara’s other passions: film, fashion, philanthropy, and technology. And as part of her ongoing philanthropy work, Ciara sits on the board of the Why Not You Foundation, a charity launched by her husband Russell Wilson dedicated to fighting poverty through education, empowering youth to lead with a ‘why not you’ attitude.

Kenneth Cole is an American designer, social activist, and visionary who believes business and philanthropy are interdependent. His global company, Kenneth Cole Productions, creates modern, versatile, and functional footwear, clothing, and accessories that make daily dressing effortless for Men, Women, and Kids. The brand spans over 28 product categories with 27 licensed partners. For over 35 years, Kenneth Cole has leveraged his passion and unique brand platform to make a meaningful impact on people’s wardrobes, as well as in underserved communities.

Kenneth joined amfAR’s board of directors in 1987, and on World AIDS Day in 2004, he assumed chairmanship. Under his leadership of 14 years, amfAR was instrumental in significant breakthroughs in AIDS research, treatment, and prevention for the betterment of millions globally.

In 2016, Kenneth accepted an appointment as a UNAIDS International Goodwill Ambassador with the goal of helping to end AIDS as a public health crisis by 2030.
In 2003, Kenneth joined the board of trustees of the Sundance Institute and has supported advocated for the need for independent story telling.

After the devastating earthquake in Haiti in 2010, Kenneth opened a Health Center in Cité Soleil, serving the most underserved population in the northern hemisphere, in an effort to enable access to basic healthcare services to over 1.5 million Haitians in need.

In 2020, in the midst of the COVID 19 crisis, Kenneth launched an initiative to address what was arguably an even larger pandemic: Mental Health. The Mental Health Coalition (MHC), a coalition of the nation’s leading mental health organizations, brands, and individuals who have joined forces to end the debilitating stigma surrounding mental health and to change the way people talk about, and care for, mental illness.

The Coalition’s mission is to build a like-minded community who will work together to destigmatize all mental health conditions, and enable equitable access to vital resources and support for all. The Mental Health Coalition was formed with the understanding that the mental health crisis is fueled by a pervasive and devastating stigma, preventing millions of individuals from being able to seek the critical treatment they need. MHC is committed to not relent until mental health is no longer associated with stigma, shame, or judgement and all people feel empowered to openly discuss and address their individual mental health needs.

Michael M. Crow is an educator, knowledge enterprise architect, science and technology policy scholar and higher education leader. He became the sixteenth president of Arizona State University in 2002 and has spearheaded ASU’s rapid and groundbreaking transformation into one of the world’s best public metropolitan research universities. As a New American University, ASU simultaneously demonstrates excellence, access and social impact.

John F. Crowley is the Chairman and CEO of Amicus Therapeutics, a global biotechnology company focusing on developing treatments for rare genetic diseases. John has been Amicus CEO since 2005 and has overseen the company’s growth from a four person start-up to one with operations in more than 30 countries, with 550+ employees and a market value of nearly $3 Billion. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder. In his drive to find a cure for them, he left his position at Bristol-Myers Squibb and became an entrepreneur as the Co-founder, President and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for Pompe disease (which he credits as ultimately saving his children's lives). In 2001, Novazyme was acquired by Genzyme Corporation and John continued to play a lead role in the development of a drug for Pompe disease as Senior Vice President, Genzyme Therapeutics. John and his family have been profiled on the front page of The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, "The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children." The major motion picture, Extraordinary Measures, starring Brendan Fraser and Harrison Ford, is inspired by the Crowley family journey. John is the author of a personal memoir: Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. John served as a commissioned intelligence officer in the U.S. Navy Reserve from 2005-2016, assigned to the United States Special Operations Command and is a veteran of the global war on terrorism, with service in Afghanistan. He graduated with a B.S. in Foreign Service from Georgetown University, and earned a J.D. from the University of Notre Dame Law School and an M.B.A. from Harvard. The Crowley family was the recipient of the 2011 Family Exemplar Award from the University of Notre Dame. He is also a member of the University Council on Science & Technology at Notre Dame. John served as the National Chairman of the Make-A-Wish Foundation of America (2014-2016) and is a founding Board member of the Global Genes Project. John is a Henry Crown Fellow at the Aspen Institute.

Karen B. DeSalvo, MD, MPH, MSc is the Chief Health Ocer of Google Health. She is a physician executive working at the intersection of medicine, public health, and information technology whose career has focused on improving health and eliminating disparities. She leads a team of health professionals at Google who provide clinical guidance for the development of inclusive research, products and services. Prior to joining Google, Dr. DeSalvo was National Coordinator for Health Information Technology and acted as the Assistant Secretary for Health in the Obama Administration. During her time at the U.S. Depament of Health and Human Services, Dr. DeSalvo focused on creating a more consumer-oriented, transparent and value-based health system. Dr. DeSalvo served as the New Orleans Health Commissioner following Hurricane Katrina. Prior to that she was Vice Dean for Community Aairs and Health Policy at the Tulane School of Medicine where she was a practicing internal medicine physician, educator, researcher and leader. She serves on the Council of the National Academy of Medicine.

Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis is the Founder and Executive Chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the Executive Founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world’s leaders on exponentially growing technologies.

As an entrepreneur, Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education. He is Co-founder and Vice-Chairman of Celularity, Inc., a cellular therapeutics company, and of Vaxxinity, Inc. which develops vaccines to harness the immune system against COVID and chronic diseases. Diamandis is Co-founder & Chairman of Fountain Life, a fully-integrated platform delivering predictive, preventative, personalized and data-driven health. Finally, he also serves as Co-founder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies.

Diamandis is a New York Times Bestselling author of three books: Abundance – The Future Is Better Than You Think, BOLD – How to go Big, Create Wealth & Impact the World and The Future is Faster Than You Think.

He earned degrees in molecular genetics and aerospace engineering from MIT and holds an M.D. from Harvard Medical School. Diamandis’ favorite saying is “The best way to predict the future is to create it yourself.”

Deborah DiSanzo is president of Best Buy Health for Best Buy Co. Inc. In this role, she is responsible for the company’s health strategy, with a particular focus on bringing health technology into the home to help people live better, safer and more independent lives.

Her oversight of Best Buy Health includes GreatCall, a leading provider of connected health and personal emergency response services to the aging population, which Best Buy acquired in 2018. She also leads the incubation, strategy and corporate development teams focused on scaling health initiatives at Best Buy.

Deborah is an innovative, strategic leader with more than 30 years of experience at the intersection of health care and technology. She is a recognized thought leader in artificial intelligence and big data, has deep experience in running businesses known for their innovation in health care, and has a demonstrated ability to drive growth both organically and through acquisitions.

Most recently, Deborah served as an instructor at the Harvard T.H. Chan School of Public Health. Prior to that, she led the IBM Watson Health team, launching artificial intelligence offerings designed to help doctors, researchers, health care providers, pharmacists and insurers better serve patients around the world. Deborah was also CEO of Philips Healthcare, where she and her team brought consumer-grade, automatic defibrillators to the market, making them first available in public places then, ultimately, in the homes of Americans across the country.

Deborah holds a bachelor’s degree from Merrimack College and an MBA from Babson College. She continues to teach at the Harvard T.H. Chan School of Public Health and serves on the boards of AstraZeneca and Novanta Inc.

Chris, who joined Flexential in 2016, is responsible for setting and managing the strategic priorities of the company to drive profitability and growth. He is a proven Chief Executive Officer with deep expertise in the economics, delivery and operations in the data center and hybrid IT industries. Chris is a well-known speaker at industry, business, and regional events.

Before Flexential, Chris was Chief Executive Officer at Telx Holdings, a leading interconnection and data center solutions provider based in New York City. He has more than 30 years of executive leadership experience in finance and operations, working for Bear Stearns, Daniels & Associates, BroadStreet Communications and Motient Corporation.

Chris holds a bachelor’s degree in History from Dartmouth College and a master’s degree in International Business from New York University.

Ben duPont, is co-founder and managing partner at Chartline Capital Partners, a Venture Capital Fund that has 20 portfolio companies and invests in enterprise technology companies in: Digital Health, Retail Analytics, Telecom Infrastructure, Digital Industrial and Food Supply Chain.

Prior to Chartline Capital Partners, Ben co-founded yet2.com, an open innovation, technology scouting and patent pooling firm, holding the position as president from 1999 to 2016. In 2000, yet2.com was funded by Siemens, Bayer, Caterpillar, P&G, Honeywell, DuPont and NTT.

For several years, Ben worked for DuPont, a global materials science, chemical and agriculture company, and held various management positions across business units including automotive, fibers, specialty chemicals and engineering.

Renée Fleming is one of the most highly acclaimed singers of our time, performing on the stages of the world’s greatest opera houses and concert halls. Honored with four Grammy® awards and the US National Medal of Arts, Renée has sung for momentous occasions from the Nobel Peace Prize ceremony to the Diamond Jubilee Concert for Queen Elizabeth II at Buckingham Palace. In 2014, she brought her voice to vast new audience as the first classical artist ever to sing The Star-Spangled Banner at the Super Bowl.

In May, Renée launched Music and Mind LIVE, a weekly web series exploring the intersection of music and arts with human health and the brain. In 19 episodes, the show amassed more than 650,000 views, from 70 countries. Renée was inspired to launch the series by the Sound Health initiative she leads as Artistic Advisor to the John F. Kennedy Center for the Performing Arts, in partnership with the NIH and the NEA. She has given presentations with scientists and practitioners on the connection of arts and health around the world.

Earning 17 Grammy nominations, Renée has recorded everything from complete operas and song recitals to jazz and indie rock. Her voice is featured on the soundtracks of Best Picture Oscar winners The Shape of Water and The Lord of the Rings: The Return of the King.

Renée’s other awards include the Fulbright Lifetime Achievement Medal, Germany’s Cross of the Order of Merit, and France’s Chevalier de la Légion d’Honneur. www.reneefleming.com

Kristen Fortney is the co-founder and CEO of BioAge, a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging. By targeting these pathways with a large and mechanistically diverse portfolio of drugs, BioAge will unlock opportunities to treat or even prevent diseases of aging in entirely new ways.

Kristen’s scientific background is in aging biology and bioinformatics. She received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University where she was a fellow of the Ellison Medical Foundation / American Federation for Aging Research.

Pat Geraghty is President and Chief Executive Officer of GuideWell, a $20 billion mutual insurance holding company headquartered in Jacksonville, Fla. A mission-driven health solutions enterprise, GuideWell is the parent to a family of forward-thinking companies focused on transforming health care.

GuideWell comprises Florida Blue, the leading health insurance company in Florida; GuideWell Health, a portfolio of clinical delivery organizations; GuideWell Venture Group, a portfolio of companies, including Onlife Health and PopHealthCare, focused on creating human-first and innovative health solutions for health plans; GuideWell Source, a provider of administrative services to state and federal health care programs; and WebTPA, a market leading administrator of self-funded employer health plans. GuideWell serves more than 45 million people across 45 states, including more than 5 million individuals in Florida.

Geraghty was the architect of the strategic restructuring that created GuideWell from the foundation of a 75-year-old health insurance company, transforming it into a health solutions organization at the forefront of reimagining the future of health in America. The GuideWell restructuring is considered a model of strategic reinvention and is featured as a capstone business case in the curriculum of Harvard Business School.

A dynamic speaker, Geraghty is considered an expert voice on a range of health care topics including health care reform in the U.S., next-generation payment strategies, innovation in health care and the benefits of wellness and prevention programming.

He has appeared on NBC’s “Meet the Press,” “Fox Business News,” CNBC’s “Closing Bell,” The Wall Street Journal’s “Money Beat,” “PBS Nightly Business Report,” MSNBC’s “Morning Joe” and Bloomberg TV’s “Street Smart” and “Capitol Gains” programs. Geraghty also has been featured on the front page of The New York Times’ Business Day, in The Wall Street Journal, and in many other media outlets.

In addition to serving as an expert source to leading news media, Geraghty is frequently sought after for his insights on important health care policy matters in Washington, D.C. and Tallahassee, Fla.

Geraghty is active in leading professional and community organizations. He is past chair of the Florida Council of 100, a private, non-profit, non-partisan organization of Florida business leaders who advise the state’s governor on how to improve the economic growth of the state and the economic well-being of its residents.

He also serves as a member of the board of the National Institute of Health Care Management (NIHCM), a non-profit organization dedicated to improving the effectiveness, efficiency and quality of America’s health care system; America’s Health Insurance Plans (AHIP); and Tampa Electric Co. (TECO).

In 2016 Geraghty became a member of the Health Governors Community of the World Economic Forum, the international organization for public private cooperation, and a trustee for its Global Challenge Initiative on The Future of Health.

Geraghty holds a Bachelor of Arts degree from Colgate University and a Doctor of Humane Letters, honoris causa, degree from Florida Southern College. He also has completed executive education programs at Harvard University School of Public Health and the Wharton School at the University of Pennsylvania.

Keith A. Grossman is the President of TIME, where he oversees all business, technology and operational responsibility for the brand. Previously, Keith served as the Global Chief Revenue Officer for Bloomberg Media where he was responsible for the growth of their various media platforms. He was also part of the core team to launch QuickTake by Bloomberg, a 24/7 social, mobile news platform. Prior to Bloomberg, Keith was the Associate Publisher of WIRED as well as Ars Technica.

Keith is currently the Chairman of Adweek's Advisory Board and has been named to the Adweek 50, which recognizes the 50 most indispensable individuals in media, marketing and tech, from 2013 through 2018 and in 2020.

Under Keith's leadership at Bloomberg, the team won a Gold Dolphin at the Cannes Corporate Media & TV Awards in 2019 for their partnership with Hyundai on a series titled, Art + Technology, and his teams at WIRED and Ars Technica were each recognized with Project Isaac Awards, celebrating true invention across the media and marketing industry.

He is a Board Member of New York Cares, New York's largest volunteer network connecting individuals within their philanthropic passions and, previously, was an Adjunct Professor at NYU.

Keith is a graduate of Cornell University and currently resides in New York City with his wife, Catherine, and daughter, Ellie.

Dr. Sanjay Gupta is the multiple Emmy®-award winning chief medical correspondent for CNN and host of the CNN podcast Chasing Life. Gupta, a practicing neurosurgeon, plays an integral role in CNN's reporting on health and medical news for all of CNN's shows domestically and internationally, and regularly contributes to CNN.com.

In addition to his work for CNN, Gupta is an associate professor of neurosurgery at Emory University Hospital and associate chief of neurosurgery at Grady Memorial Hospital in Atlanta. He serves as a diplomate of the American Board of Neurosurgery. And in 2019, Gupta was elected to the National Academy of Medicine, considered one of the highest honors in the medical field.

In 2021, Gupta co-founded LIFE ITSELF conference with Marc Hodosh of TEDMED.

Randy Haffner is president and CEO of AdventHealth’s Central Florida Division, which encompasses more than 20 hospitals and ERs in the seven counties in and surrounding metro Orlando. The world-class hospitals, combined with a comprehensive outpatient care network, treats more than 3.4 million patient visits annually.

Randy has been with AdventHealth since 1989 and has held senior leadership positions throughout the organization. As president/CEO of the multi-state division, Randy oversaw AdventHealth’s operations outside of Florida, comprising of 20 campuses across eight states. He also previously served as CEO of Porter Adventist Hospital in Colorado, and as administrator of AdventHealth Orlando.

Randy graduated from Walla Walla College, earned his graduate degree from the Roy E. Crummer Graduate School of Business at Rollins College, and a doctorate in leadership studies from Andrews University.

He is a member of the Florida Hospital Association Board and the Orlando Economic Partnership’s Governor’s Council.

Randy and his wife Cindy have three children. In his spare time, he enjoys spending time outdoors including running, cycling and snow skiing.

Dr. Bob Hariri is an accomplished surgeon, biomedical scientist, and serial entrepreneur in two technology sectors, biomedicine and aerospace. He is the chairman, founder, and chief executive officer of Celularity, Inc., (NASDAQ: CELU) one of the world's leading human cellular therapeutics companies. Dr. Hariri served as CEO of Cellular Therapeutics Division of Celgene (NASDAQ:CELG). Dr. Hariri also co-founded the genomic-based health intelligence company, Human Longevity, Inc. and serves as a director Cryoport (NASDAQ:CYRX).

Dr. Hariri pioneered the use of stem cells to treat a range of human diseases making transformative contributions in the fields of immuno-oncology, cellular therapy, tissue engineering and functional regeneration. He is widely acknowledged for his discovery of pluripotent stem cells derived from the human placenta, and as a member of the team that discovered the physiological activities of tumor necrosis factor (TNF). Celularity was the first to obtain FDA approval to use its cryopreserved allogeneic, off-the-shelf Natural Killer (NK) cell therapy to treat COVID-19 infected adults. He holds over 200 issued and pending patents and has authored over 150 published chapters, articles, and abstracts.

Dr. Hariri was the recipient of the Pontifical Medal for Innovation awarded by Pope Francis in 2018 for advances in immunotherapy and regenerative medicine. Dr. Hariri received the Thomas Alva Edison Award in 2007, 2011, 2021 and the recipient of the Children’s Brain Tumor Foundation’s Fred J. Epstein Lifetime Achievement Award as well as the Genius of New Jersey Award in 2019 and over the years has received numerous other honors for his many in biomedicine and aviation.

Dr. Hariri is an Adjunct Professor of Neurosurgery and member of the Board of Overseers of the Weill Cornell Medical College and a former member of the board of visitors of the Columbia University School of Engineering and Applied Sciences and is a trustee and vice-chair of the Liberty Science Center. In 2010 he was appointed a Commissioner of Cancer Research by New Jersey Governor Chris Christie.

Dr. Hariri completed his undergraduate training at Columbia University School of Engineering and Applied Sciences and Columbia College. He received his M.D. and Ph.D. degrees from Cornell University, where he was the recipient of both the Julian R. Rachele Award and the Doctoral Dissertation Award. He was a surgical resident and fellow in neurosurgery at The New York Hospital-Cornell Medical Center.

When he is not in the laboratory or the corporate boardroom, Dr. Hariri is a jet-rated commercial pilot with thousands of hours of flight time in over 60 different military and civilian aircraft. He has also produced several feature films, as well as documentaries on global societal issues.

Patrice A. Harris, MD, MA is the CEO and Co-Founder of eMed, a digital healthcare company. She is a board certified psychiatrist from Atlanta and has diverse experience as a private practicing physician, county public health director and patient advocate and expertise in policy, legislative and government affairs. Dr. Harris was the 174th President of the American Medical Association and the first African American woman elected to that position. Dr. Harris is a visiting professor of psychiatry at the Columbia University Vagelos College of Physicians and Surgeons and serves as Chief Health and Medical Editor of Everydayhealth.com.

Beyond the AMA she has held positions of leadership with the American Psychiatric Association, the Georgia Psychiatric Physicians Association, the Medical Association of Georgia, and The Big Cities Health Coalition, where she chaired this forum composed of leaders from America’s largest metropolitan health departments. She is a member of the Steering Committee of the Atlanta Regional Collaborative for Health Improvement (ARCHI) and the Board of the Georgia Aids Coalition. She also serves on the Board of Quartet Health.

Dr. Harris spent her formative years at West Virginia University, earning a BA in psychology, an MA in counseling psychology and, ultimately, a medical degree (MD). She completed her psychiatry residency and fellowships in child and adolescent psychiatry and forensic psychiatry at the Emory University School of Medicine

Dr. Harris is a highly sought after speaker at national and international conferences and has given invited lectures and presentations on COVID-19, children’s mental health, childhood trauma, integration of mental health into overall health services, health equity, health policy and the intersection of athletics and health. She has been a guest expert on multiple national radio and television networks including CNN, MSNBC, Fox and NPR. Dr. Harris has received numerous awards in recognition of her service and leadership.

Dr. Harris is fellow of the American Psychiatric Association and is adjunct assistant professor in the Emory Department of Psychiatry and Behavioral Sciences, and an adjunct clinical assistant professor in psychiatry and behavioral sciences at the Morehouse School of Medicine.

Goldie Hawn is an Academy Award winning actress, producer, director, best-selling author and true children’s advocate. She is the Founder of The Goldie Hawn Foundation, a public charity with a mission to equip children with the social and emotional skills they need to lead smarter, healthier, happier and ultimately more productive lives.

Alarmed by increases in school violence, youth depression and suicide, and the persistent failure of the education system to help children cope with increasingly stressful lives, Hawn started The Goldie Hawn Foundation in 2003, applying cutting edge scientific research to create education programs that support the social and emotional development of children. Working with leading neuroscientists, educators, psychologists and researchers, the Foundation developed MindUP™ an evidence-based curriculum and teaching model for grades K-12 that provide tools to help children self-regulate and understand their own emotions, reduce stress and anxiety, sharpen concentration, increase empathy, and improve academic performance.

MindUP™ is the signature program of The Goldie Hawn Foundation which is serving over six million children in the US, Canada, UK, Finland, Ireland, Greece, Venezuela, Uganda, Portugal, Serbia, Jordan, Hong Kong, Australia, and New Zealand. The skills and mindfulness practices that are being taught have helped children improve learning and academic performance and learn valuable social and emotional skills that build personal resilience for a lifetime.

Hawn authored two best-selling books, a memoir “A Lotus Grows in the Mud”, in 2005 and in 2011, “10 Mindful Minutes”, offering guidance on raising healthy, joyful and resilient children. In 2015, Hawn released “10 Mindful Minutes: A Journal”, a practical application to her last book, offering prompts and exercises to enhance the reader’s daily life through mindfulness practice.

Goldie has lived with her partner Kurt Russell for over 30 years and has four grown children, Oliver and Kate Hudson, Wyatt Russell and stepson Boston Russell. They have also been blessed with seven grandchildren. Hawn believes “children light the path to joy” and dedicated much of her life’s work to creating innovative solutions to help children thrive.

Sam Hazen is chief executive officer of HCA Healthcare, one of the nation’s leading providers of healthcare services with 185 hospitals and approximately 2,000 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers and physician clinics, in 20 states and the United Kingdom. Based in Nashville, Tennessee, HCA Healthcare and its 275,000 employees provide approximately six percent of all U.S. inpatient hospital services.

A 38-year veteran of HCA Healthcare, Hazen was appointed CEO January 1, 2019 after serving as president and chief operating officer since 2016. Hazen has served in various senior positions for HCA Healthcare including president of operations from 2011-2015. Hazen has also served as president of HCA Healthcare’s Western Group, which included all operations west of the Mississippi River and represented approximately one-half of the company’s revenue.

Prior to 2001, Hazen was chief financial officer for the Western Group. Prior to 1995, he was chief financial officer for two different divisions in the company, overseeing operations in North Texas and various other markets. Hazen began his career in Humana’s Financial Management Specialist Program in 1983 and has held chief financial officer position at hospitals in Georgia and Las Vegas.

Hazen currently serves on the Board of Directors for the Nashville Health Care Council, Federation of American Hospitals, and the HCA Healthcare Foundation.

Hazen earned his bachelor’s degree in finance from the University of Kentucky and his master’s degree in business administration from the University of Nevada Las Vegas.

Dr. He has been serving as Executive Chairman of Human Longevity Inc since July 2019. Prior to HLI, Dr. He was the CEO of OriGene Technologies, Inc. and remains Chairman of the Board of Directors. He also is the founder and General Partner of Emerging Technology Partners, LLC (ETP), a life sciences focused venture fund established since 2000. Dr. He has been involved in founding or funding over 60 biotech companies throughout his career, some of which went on to be acquired by significantly larger firms. In the earlier part of his career, Dr. He was one of the first few scientists at Human Genome Sciences, and prior to that, was a research fellow at Massachusetts General Hospital and Mayo Clinic. Dr. He is an author to more than 30 research publications and inventor of over 32 issued patents. Dr. He received his PhD in Molecular Biology from Baylor College of Medicine and received an MBA degree from the Wharton School.

Hugh Herr is creating bionic limbs that emulate the function of natural limbs. Time Magazine coined Dr. Herr the ‘Leader of the Bionic Age’ because of his revolutionary work in the emerging field of Biomechatronics - technology that marries human physiology with electromechanics. A double amputee himself, he is responsible for breakthrough advances in bionic limbs that provide greater mobility and new hope to those with physical disabilities. He is currently Professor of Media Arts and Sciences at the MIT Media Lab, and co-leads the Yang Center for Bionics at MIT.

Herr is the author and co-author of over 200 peer-reviewed manuscripts and patents, chronicling the science and technology behind his many innovations. These innovations include active Leg Exoskeletons, Powered Ankle-Foot Prostheses, and neural interfacing technologies. A powered ankle-foot prosthesis called EmPower, which emulates the action of a biological leg and, for the first time, provides amputees with a natural gait, was named to the list of Top Ten Inventions in the health category by TIME magazine in 2007. Today the EmPower Ankle-Foot Prosthesis has been clinically shown to be the first leg prosthesis in history to reach human normalization, allowing amputees to walk with normal levels of speed and metabolism as if their legs were biological once again.

In 2015, Herr’s MIT research group invented the Agonist-Antagonist Myoneural Interface, a novel surgical procedure for limb amputation and neural interfacing that allows persons with limb loss to control their synthetic limbs through thought, as well as to experience natural proprioceptive sensations from the synthetic limb. Herr has received many accolades for his groundbreaking innovations, including the 13th Annual Heinz Award for Technology, the Economy and Employment; the Prince Salman Award for Disability Research; the Smithsonian American Ingenuity Award in Technology, the 14th Innovator of the Year Award, and the 41st Inventor of the Year Award, and the 2016 Princess of Asturias Award for Technical & Scientific Research. Hugh's story has been told in a National Geographic film, Ascent: The Story of Hugh Herr; and episodes and articles featured in CNN, The Economist, Discover and Nature.

As the President and CEO of the International WELL Building Institute (IWBI), Rachel is leading a movement to advance human health through better buildings, more vibrant communities, and stronger, more equitable organizations. Her motto is “Always be winning for good,” and she’s put that to work at IWBI, developing research-backed tools to help organizations create places where people thrive. Today, these “people-first places” extend across 3.5 billion square feet of space in 109 countries.

Prior to joining IWBI, Rachel spent nearly a decade at the intersection of sustainability and human health, helping the U.S. Green Building Council (USGBC) make LEED the world’s most widely used green building rating system. At USGBC, she founded the Center for Green Schools, which mobilized $275B+ investments in LEED-certified educational facilities and deployed over 750,000 volunteers to transform schools on every continent.

Rachel serves on numerous boards and advisories for organizations ranging from the, Paul Hawken’s Project Regeneration, OutLeadership and the Walgreens CSR Advisory Council. A graduate of Tufts University, she is a sought-after media voice, inspirational speaker and frequent guest lecturer and instructor.

Kevin B. Johnson, MD, MS is an internationally known expert in biomedical informatics and pediatrics, and a well-known communicator of science. His research spans the translational science spectrum, and includes developing tools to acquire clinical information, clinical tools to support sharing and transforming clinical information, and evaluations of new paradigms for clinical information use and management.

Dean Kamen is the founder and president of DEKA Research & Development Corporation. Examples of technologies developed by DEKA include the HomeChoice™ portable dialysis machine, the iBOT™ Mobility System, the Segway™ Human Transporter, a DARPA-funded robotic arm, a new and improved Stirling engine, and the Slingshot water purifier.

Kamen has received many awards for his efforts, including the National Medal of Technology in 2000 and the Lemelson-MIT Prize in 2002. He was inducted into the National Inventors Hall of Fame in 2005 and has been a member of the National Academy of Engineering since 1997.

Among Kamen’s proudest accomplishments is founding FIRST (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology.